Weekly Digest – January 2025 Weekly Digest – January 2025 16 Jan 2025: Innovent receives NMPA Breakthrough Therapy Designation for IBI343 (anti-CLDN18.2 ADC) as monotherapy for advanced Pancreatic Cancer Innovent Biologics received Breakthrough Therapy Designation (BTD) from the NMPA for […]
Weekly Digest – January 2025 Weekly Digest – January 2025 13 Jan 2025: Datopotamab deruxtecan granted Priority Review in the US for patients with previously treated advanced EGFR-mutated Non-Small Cell Lung Cancer Datopotamab deruxtecan (Dato-DXd) received FDA Priority Review for […]
Weekly Digest – January 2025 Weekly Digest – January 2025 10 Jan 2025: Mersana Therapeutics announces additional FDA Fast Track Designation granted to Emiltatug Ledadotin (XMT-1660) XMT-1660 (Emi-Le) received a new Fast Track designation for advanced or metastatic HER2-low or HER2-negative […]
